Susquehanna International Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,853
Closed -$54K 7337
2024
Q4
$54K Buy
100,853
+26,974
+37% +$14.4K ﹤0.01% 5849
2024
Q3
$130K Sell
73,879
-427,918
-85% -$753K ﹤0.01% 5021
2024
Q2
$587K Buy
501,797
+397,907
+383% +$466K ﹤0.01% 3282
2024
Q1
$939K Sell
103,890
-40,014
-28% -$362K ﹤0.01% 2728
2023
Q4
$1.56M Buy
143,904
+10,814
+8% +$118K ﹤0.01% 2225
2023
Q3
$1.07M Buy
133,090
+67,573
+103% +$544K ﹤0.01% 2486
2023
Q2
$712K Sell
65,517
-287,688
-81% -$3.12M ﹤0.01% 3162
2023
Q1
$2.44M Sell
353,205
-13,360
-4% -$92.2K ﹤0.01% 1752
2022
Q4
$1.46M Buy
366,565
+329,660
+893% +$1.31M ﹤0.01% 1911
2022
Q3
$245K Buy
36,905
+10,139
+38% +$67.3K ﹤0.01% 4505
2022
Q2
$130K Sell
26,766
-4,832
-15% -$23.5K ﹤0.01% 4867
2022
Q1
$295K Sell
31,598
-42,086
-57% -$393K ﹤0.01% 4364
2021
Q4
$875K Sell
73,684
-5,149
-7% -$61.1K ﹤0.01% 3029
2021
Q3
$897K Buy
78,833
+49,880
+172% +$568K ﹤0.01% 2905
2021
Q2
$519K Sell
28,953
-232,432
-89% -$4.17M ﹤0.01% 3843
2021
Q1
$4.05M Buy
261,385
+41,439
+19% +$641K ﹤0.01% 1417
2020
Q4
$2.68M Buy
219,946
+118,949
+118% +$1.45M ﹤0.01% 1486
2020
Q3
$1.3M Buy
100,997
+19,127
+23% +$246K ﹤0.01% 1894
2020
Q2
$832K Sell
81,870
-33,580
-29% -$341K ﹤0.01% 2353
2020
Q1
$937K Buy
115,450
+1,689
+1% +$13.7K ﹤0.01% 2122
2019
Q4
$983K Buy
113,761
+46,305
+69% +$400K ﹤0.01% 1919
2019
Q3
$416K Sell
67,456
-21,581
-24% -$133K ﹤0.01% 3092
2019
Q2
$1.48M Buy
89,037
+59,532
+202% +$988K ﹤0.01% 1587
2019
Q1
$493K Buy
+29,505
New +$493K ﹤0.01% 1858
2018
Q4
Hold
0
5092
2018
Q3
Hold
0
4933
2018
Q2
Sell
-101,548
Closed -$1.55M 4928
2018
Q1
$1.55M Buy
101,548
+84,507
+496% +$1.29M ﹤0.01% 1143
2017
Q4
$556K Sell
17,041
-4,364
-20% -$142K ﹤0.01% 2309
2017
Q3
$503K Buy
+21,405
New +$503K ﹤0.01% 2154
2016
Q4
Sell
-14,442
Closed -$105K 4891
2016
Q3
$105K Buy
+14,442
New +$105K ﹤0.01% 2696